University in Madison, Wisconsin, US

In Dec 2011, a 42-year-old lady was remarked our department. The patient was antecedently diagnosed with carcinoma in Gregorian calendar month 2009. She received six courses of therapy once having breast neoplasm surgery, and achieved complete remission (CR) once therapy. Then estrogen antagonist was given for six months as a succeeding endocrine medical aid. In Sep 2011, the patient was diagnosed with acute myeloid leukemia-M2 (AML-M2) thanks to a fever of thirty-nine.0. The routine biopsy indicated that the white blood count(WBC) was forty three.67×109/L, absolute white blood cell count (ANC) was zero.8×109/L, haemoprotein was fifty seven g/L, platelets count was 22×109/L, and also the myeloblasts accounted for forty eighth within the peripheral blood also as seventy nine within the bone marrow.

William Stolarek . Refractory Secondary Acute Myeloid Leukemia with 12-O-Tetradecanoylphorbol-13-Acetate. Insights Journal of Surgery and Clinical Case Reports 2021.